Ningbo David Medical Device Co Ltd
Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and sales of pediatric childcare equipment, surgical instruments and other products worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It also offers other products, such as infusion pumps, tra… Read more
Market Cap & Net Worth: Ningbo David Medical Device Co Ltd (300314)
Ningbo David Medical Device Co Ltd (SHE:300314) has a market capitalization of $527.54 Million (CN¥3.87 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #15712 globally and #4187 in its home market, demonstrating a -3.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ningbo David Medical Device Co Ltd's stock price CN¥13.44 by its total outstanding shares 288000000 (288.00 Million).
Ningbo David Medical Device Co Ltd Market Cap History: 2015 to 2026
Ningbo David Medical Device Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.25 Billion to $527.54 Million (-9.04% CAGR).
Ningbo David Medical Device Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ningbo David Medical Device Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.84x
Ningbo David Medical Device Co Ltd's market cap is 0.84 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
7.72x
Ningbo David Medical Device Co Ltd's market cap is 7.72 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.25 Billion | $219.43 Million | $44.93 Million | 5.68x | 27.74x |
| 2016 | $780.02 Million | $264.95 Million | $62.17 Million | 2.94x | 12.55x |
| 2017 | $487.97 Million | $303.91 Million | $47.03 Million | 1.61x | 10.38x |
| 2018 | $308.72 Million | $300.30 Million | $28.81 Million | 1.03x | 10.71x |
| 2019 | $349.47 Million | $356.35 Million | $62.06 Million | 0.98x | 5.63x |
| 2020 | $616.49 Million | $459.53 Million | $136.19 Million | 1.34x | 4.53x |
| 2021 | $515.42 Million | $474.13 Million | $80.21 Million | 1.09x | 6.43x |
| 2022 | $497.32 Million | $506.04 Million | $97.36 Million | 0.98x | 5.11x |
| 2023 | $584.44 Million | $618.30 Million | $147.61 Million | 0.95x | 3.96x |
| 2024 | $441.98 Million | $527.03 Million | $57.26 Million | 0.84x | 7.72x |
Competitor Companies of 300314 by Market Capitalization
Companies near Ningbo David Medical Device Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Ningbo David Medical Device Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Ningbo David Medical Device Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Ningbo David Medical Device Co Ltd's market cap moved from $1.25 Billion to $ 527.54 Million, with a yearly change of -9.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥527.54 Million | +6.84% |
| 2025 | CN¥493.79 Million | +11.72% |
| 2024 | CN¥441.98 Million | -24.38% |
| 2023 | CN¥584.44 Million | +17.52% |
| 2022 | CN¥497.32 Million | -3.51% |
| 2021 | CN¥515.42 Million | -16.39% |
| 2020 | CN¥616.49 Million | +76.40% |
| 2019 | CN¥349.47 Million | +13.20% |
| 2018 | CN¥308.72 Million | -36.74% |
| 2017 | CN¥487.97 Million | -37.44% |
| 2016 | CN¥780.02 Million | -37.42% |
| 2015 | CN¥1.25 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Ningbo David Medical Device Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $527.54 Million USD |
| MoneyControl | $527.54 Million USD |
| MarketWatch | $527.54 Million USD |
| marketcap.company | $527.54 Million USD |
| Reuters | $527.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.